Kaoru Tsuchiya

6.2k total citations · 1 hit paper
140 papers, 3.2k citations indexed

About

Kaoru Tsuchiya is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Kaoru Tsuchiya has authored 140 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Hepatology, 88 papers in Epidemiology and 22 papers in Oncology. Recurrent topics in Kaoru Tsuchiya's work include Liver Disease Diagnosis and Treatment (75 papers), Hepatocellular Carcinoma Treatment and Prognosis (53 papers) and Hepatitis C virus research (50 papers). Kaoru Tsuchiya is often cited by papers focused on Liver Disease Diagnosis and Treatment (75 papers), Hepatocellular Carcinoma Treatment and Prognosis (53 papers) and Hepatitis C virus research (50 papers). Kaoru Tsuchiya collaborates with scholars based in Japan, United States and France. Kaoru Tsuchiya's co-authors include Namiki Izumi, Masayuki Kurosaki, Hiroyuki Nakanishi, Jun Itakura, Yutaka Yasui, Nobuharu Tamaki, Yuka Takahashi, Yasuhiro Asahina, Nobuyuki Enomoto and Ken Ueda and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Kaoru Tsuchiya

127 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan

2014 456 citations Masatoshi Kudo, Osamu Matsui et al. Liver Cancer profile →

Peers

Countries citing papers authored by Kaoru Tsuchiya

Since Specialization

Citations

This map shows the geographic impact of Kaoru Tsuchiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaoru Tsuchiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaoru Tsuchiya more than expected).

Fields of papers citing papers by Kaoru Tsuchiya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaoru Tsuchiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaoru Tsuchiya. The network helps show where Kaoru Tsuchiya may publish in the future.

Co-authorship network of co-authors of Kaoru Tsuchiya

This figure shows the co-authorship network connecting the top 25 collaborators of Kaoru Tsuchiya. A scholar is included among the top collaborators of Kaoru Tsuchiya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaoru Tsuchiya. Kaoru Tsuchiya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Depth and Duration of Response Are Associated with Survival in Patients with Unresectable Hepatocellular Carcinoma: Exploratory Analyses of IMbrave150 2025 ·Liver Cancer ·(unknown), Tatsuya Yamashita, Richard S. Finn, Peter R. Galle, Michel Ducreux, Ann‐Lii Cheng, Kaoru Tsuchiya, Naoya Sakamoto, Shuhei Hige, (unknown), Kyoko Yamada, Yuki Nakagawa, Hayato Takahashi, (unknown)	2
2	Effect of Pemafibrate on Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Nationwide Multicenter Study 2025 ·JGH Open ·Yasuyuki Komiyama, Nobuharu Tamaki, Keiji Tsuji, Nami Mori, Toshie Mashiba, (unknown), Haruhiko Kobashi, Chikara Ogawa, (unknown), (unknown), Takehiro Akahane, Masahiko Kondo, (unknown), Hideki Fujii, Yasushi Uchida, Hirotaka Arai, Kaoru Tsuchiya, Namiki Izumi, (unknown)	1
3	Primary Analysis of a Phase II Study of Atezolizumab plus Bevacizumab for TACE-Unsuitable Patients with Tumor Burden beyond Up-To-Seven Criteria in Intermediate-Stage Hepatocellular Carcinoma: REPLACEMENT Study 2025 ·Liver Cancer ·Masatoshi Kudo, Kazuomi Ueshima, Kaoru Tsuchiya, Tatsuya Yamashita, Shigeo Shimose, Kazushi Numata, Yuzo Kodama, Shinji Itoh, Yasuhito Tanaka, Hidekatsu Kuroda, Hiroshi Aikata, Atsushi Hiraoka, Michihisa Moriguchi, Ryosuke Tateishi, Sadahisa Ogasawara, Kouji Yamamoto, Masafumi Ikeda	3
4	Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma 2025 ·BMC Cancer ·Yoshihisa Kodama, (unknown), Michihisa Moriguchi, Yoshitaka Inaba, Tatsuya Yamashita, Hideki Iwamoto, Makoto Ueno, Sadahisa Ogasawara, Teiji Kuzuya, Takahiro Kodama, Yozo Sato, Toshifumi Tada, Kaoru Tsuchiya, Hideyuki Nishiofuku, Koichiro Yamakado, Miyuki Sone, (unknown), Tetsuo Takehara, Tetsutaro Hamano, (unknown)	3
5	Atezolizumab Plus Bevacizumab for TACE ‐Unsuitable Intermediate‐Stage HCC Beyond Up‐To‐7 Criteria: Final Analysis of REPLACEMENT 2025 ·Liver International ·Kazuomi Ueshima, Kaoru Tsuchiya, Tatsuya Yamashita, Shigeo Shimose, Kazushi Numata, Yuzo Kodama, Shinji Itoh, Yasuhito Tanaka, Hidekatsu Kuroda, Kazuyoshi Ohkawa, Teiji Kuzuya, (unknown), (unknown), Hiroshi Aikata, Atsushi Hiraoka, Michihisa Moriguchi, Ryosuke Tateishi, Sadahisa Ogasawara, Kouji Yamamoto, Masatoshi Kudo	0
6	Glycemic control target for liver and cardiovascular events risk in metabolic dysfunction‐associated steatotic liver disease 2024 ·Hepatology Research ·Nobuharu Tamaki, (unknown), Takefumi Kimura, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Daniel Q. Huang, Takeji Umemura, (unknown), Namiki Izumi	11
7	Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study 2023 ·Hepatology Research ·Naoya Kato, Masatoshi Kudo, Kaoru Tsuchiya, Atsushi Hagihara, Kazushi Numata, Hiroshi Aikata, Yoshitaka Inaba, Shunsuke Kondo, Kenta Motomura, Naohiro Okano, Masafumi Ikeda, Manabu Morimoto, Shingo Kuroda, Akiko Kimura	3
8	Understanding the population staying in each national park using human flow data and analyzing the location characteristics of visitor centers 2023 ·Journal of The Japanese Institute of Landscape Architecture ·(unknown), (unknown), (unknown), Kaoru Tsuchiya, (unknown)	1
9	Atezolizumab plus Bevacizumab versus Sorafenib for Unresectable Hepatocellular Carcinoma: Results from Older Adults Enrolled in the IMbrave150 Randomized Clinical Trial 2022 ·Liver Cancer ·Daneng Li, Han Chong Toh, Philippe Merle, Kaoru Tsuchiya, Sairy Hernandez, Wendy Verret, Alan Nicholas, Masatoshi Kudo	18
10	Morphometric Analysis of Mast Cells in Tumor Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation 2021 ·Hepatology Communications ·Nataliya Rohr‐Udilova, Kaoru Tsuchiya, Gerald Timelthaler, Martina Salzmann, Tobias Meischl, Katharina Wöran, Judith Stift, Merima Herac, Rolf Schulte‐Hermann, Markus Peck‐Radosavljevic, Wolfgang Sieghart, Robert Eferl, Erika Jensen‐Jarolim, Michael Trauner, Matthias Pinter	9
11	Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New Regimens 2015 ·PLoS ONE ·Nobuharu Tamaki, Masayuki Kurosaki, Mayu Higuchi, Hitomi Takada, Natsuko Nakakuki, Yutaka Yasui, Shōko Suzuki, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Shintaro Ogawa, Yasuhito Tanaka, Yasuhiro Asahina, Namiki Izumi	19
12	Transarterial Chemoembolization Failure/Refractoriness: JSH-LCSGJ Criteria 2014 Update 2014 ·Oncology ·Masatoshi Kudo, Osamu Matsui, Namiki Izumi, Masumi Kadoya, Takuji Okusaka, Shiro Miyayama, Koichiro Yamakado, Kaoru Tsuchiya, Kazuomi Ueshima, Atsushi Hiraoka, Masafumi Ikeda, Sadahisa Ogasawara, Tatsuya Yamashita, Tetsuya Minami, (unknown)	205
13	L-carnitine Reduces Muscle Cramps in Patients With Cirrhosis 2014 ·Clinical Gastroenterology and Hepatology ·Hiroyuki Nakanishi, Masayuki Kurosaki, Kaoru Tsuchiya, Natsuko Nakakuki, Hitomi Takada, Shuya Matsuda, (unknown), Yu Asano, Nobuhiro Hattori, Nobuharu Tamaki, Shōko Suzuki, Yutaka Yasui, Takanori Hosokawa, Jun Itakura, Yuka Takahashi, Namiki Izumi	47
14	A case of multiple hepatocellular carcinoma with inferior vena cava thrombosis which was resectable after multimodality therapy 2013 ·Kanzo ·Takashi Nishimura, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Masayuki Kurosaki, Yasuhiro Asahina, Atsushi Kudo, Shinji Tanaka, Namiki Izumi	0
15	Significance of PIVKA-II in sorafenib therapy for advanced hepatocellular carcinoma 2010 ·Kanzo ·Teiji Kuzuya, Kaoru Tsuchiya, (unknown), Yuichiro Suzuki, (unknown), (unknown), (unknown), Yutaka Yasui, Tomohiro Tanaka, Takanori Hosokawa, Ken Ueda, Hiroyuki Nakanishi, Jun Itakura, Masayuki Kurosaki, Yasuhiro Asahina, Namiki Izumi	1
16	Two cases of hepatic angiomyolipoma with different ultrasonographic and radiographic findings 2008 ·Kanzo ·(unknown), Yasuhiro Asahina, Kaoru Tsuchiya, Mitsuaki Sato, Tomohiro Tanaka, Yutaka Yasui, Nobutoshi Komatsu, (unknown), Takanori Hosokawa, Ken Ueda, Hiroyuki Nakanishi, Jun Itakura, Masayuki Kurosaki, Shozo Miyake, (unknown), Yoshiro Himeno, Noriaki Nakamura, Shigeki Arii, Namiki Izumi	1
17	2007 ·Journal of The Surface Finishing Society of Japan ·(unknown), Kaoru Tsuchiya, (unknown), (unknown)	2
18	Polymerase Domain B Mutation Is Associated with Hepatitis Relapse during Long-Term Lamivudine Therapy for Chronic Hepatitis B 2005 ·Intervirology ·Hiroyuki Nakanishi, Masayuki Kurosaki, Yasuhiro Asahina, (unknown), Ken Ueda, Yuki Nishimura, Kaoru Tsuchiya, Takatoshi Kitamura, Masakatsu Uchihara, Shozo Miyake, Nobuyuki Enomoto, Namiki Izumi	9
19	A case of acute severe hepatitis B caused by an HBV-Ae strain transmitted from her male sexual partner who also contracted acute hepatitis three months before 2005 ·Kanzo ·Kaoru Tsuchiya, (unknown), (unknown), (unknown), Yuki Nishimura, Hiroyuki Nakanishi, Takatoshi Kitamura, Masayuki Kurosaki, Masakatsu Uchihara, Namiki Izumi	1
20	2001 ·Kanzo ·Jun Itakura, (unknown), Kaoru Tsuchiya, Kaoru Sakurai, (unknown), (unknown), (unknown), Osamu Noguchi, Masakatsu Uchihara, Yoshiro Himeno, Shozo Miyake, Takahiro Sakai	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact